SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-24-000139
Filing Date
2024-05-07
Accepted
2024-05-07 16:14:28
Documents
80
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vrtx-20240331.htm   iXBRL 10-Q 1149933
2 EX-31.1 a2024q110-qexhibit311.htm EX-31.1 10728
3 EX-31.2 a2024q110-qexhibit312.htm EX-31.2 10726
4 EX-32.1 a2024q110-qexhibit321.htm EX-32.1 6297
10 GRAPHIC vrtx-20240331_g1.jpg GRAPHIC 63566
  Complete submission text file 0000875320-24-000139.txt   7002277

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20240331.xsd EX-101.SCH 42958
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20240331_cal.xml EX-101.CAL 83145
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20240331_def.xml EX-101.DEF 226408
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20240331_lab.xml EX-101.LAB 577958
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20240331_pre.xml EX-101.PRE 424082
84 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20240331_htm.xml XML 1107678
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 24922041
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)